652
The journal Pediatric Blood & Cancer has published a study about the childhood immune thrombocytopenia. Nationwide prospective cohort study was conducted exploring the factors associated with treatment initiation (vs. watchful waiting) in children with primary immune thrombocytopenia (ITP) followed in routine clinical practice and the predictors of chronicity at 12 months. Between 2008 and 2013, 23 centers throughout France consecutively included 257 children aged 6 months-18 years and diagnosed with primary ITP over a 5-year period. One hundred thirty-seven (53%) children were males, median age was 4.6 years, median platelet count was 7 × 10^9/l, and 214 (81%) patients initiated medication. The full-text of the study you can find here.